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Aims:We investigated whether the treatment with anthocyanins prevents the scopolamine-induced memory
deﬁcits and whether ectonucleotidase activities and purine levels are altered in the cerebral cortex (CC) and
hippocampus (HC) in this model of mnemonic deﬁcit in rats.
Main methods: The animals were divided into 4 experimental groups: control (vehicle), anthocyanins (Antho),
scopolamine (SCO), and scopolamine plus anthocyanins (SCO+Antho). After seven days of treatment, they
were tested in the inhibitory avoidance task and open ﬁeld test and submitted to euthanasia. The CC and the HC
were collected for biochemical assays. The effect of treatment with Antho (200 mg kg−1, i.p.) was investigated
in rats trained to a stable level of performance and post-treated with SCO (1 mg kg−1, i.p. 30 min after training).
Key ﬁndings: The treatment with SCO decreased the step-down latency in inhibitory avoidance task. Antho
prevented the scopolamine-induced memory impairment and also the increase of NTPDase activity in the CC
and HC. Furthermore, the treatment with anthocyanins prevents the decrease in 5′-nucleotidase activity and
the increase in adenosine deaminase activity induced by SCO in HC. In addition, the treatment with Antho
prevented the decrease in ATP levels induced by SCO in the CC and HC.
Signiﬁcance: Our results show that scopolamine may affect purinergic enzymatic cascade or cause alterations in
energy metabolism inducing loss of memory. In contrast Antho could reverse these changes, suggesting a
neuroprotective effect of Antho on ectonucleotidase activities and neuronal energetic metabolism.© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
The extracellular nucleotide ATP and its nucleoside derivative aden-
osine are important signaling molecules involved in innumerous phys-
iological and pathological functions (Bours et al., 2006; Burnstock,
2006a). It has been shown that ATP and adenosine have an array of
functions in the central nervous system (CNS) acting as neurotransmit-
ters and activating purinergic and adenosinergic receptors, respectively
(Burnstock, 2011; Zimmermann, 1996, 1999, 2006). The levels of extra-
cellular ATP and adenosine may be related to processes of learning and
memory formation, since various evidences point to LTP and LTD and
synaptic plasticity as a neural basis for cognitive processes (Cooke and
Bliss, 2006; Howland andWang, 2008; Lovinger, 2010;Malenka, 1994).zimologia Toxicológica, Centro
Santa Maria, Santa Maria, RS
Gutierres),
sevier OA license.The extracellular levels of ATP and adenosine are regulated by a
cascade of cell-surface-bound enzymes named ectonucleotidases
(Battastini et al., 1991). The NTPDase is an enzyme that hydrolyzes
ATP and ADP into AMP, which is subsequently converted to adenosine
by the enzyme 5′-nucleotidase (Battastini et al., 1991; Zimmermann,
1996, 1999, 2006).Moreover, adenosine is cleavedby the enzyme aden-
osine deaminase in inosine in the synaptic cleft (Robson et al., 2006,
2005). Together, these enzymes constitute an organized enzymatic cas-
cade for the regulation of nucleotide-mediated signaling, controlling
rate, degradation, and nucleoside formation (Abbracchio et al., 2009;
Burnstock, 2009, 2011; Schetinger et al., 2007, 2001). The involvement
of ectonucleotidases on the process of learning and memory in rats has
also been described (Bonan et al., 1998, 2000; Pereira et al., 2002).
Scopolamine (SCO) is a non-selective muscarinic cholinergic an-
tagonist which produces a transient memory impairment in rodents
(Klinkenberg and Blokland, 2010). It has been also reported that
SCO reduces frontal cortex perfusion in young humans (Honer et al.,
1988) and impairs the energetic metabolism reducing the ATP levels
in the cerebral cortex of rats (Blin et al., 1994; Ray et al., 1992). The
impairment of mitochondrial function and reduction of ATP levels
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as Alzheimer's disease (AD), which is closely linked to the decline of
cognitive processes (Ferrer, 2009; Hauptmann et al., 2009).
Anthocyanins belong to the ﬂavonoid family; they present phenolic
groups in their chemical structure and give colors to ﬂowers and fruits
of a great variety of plants (Veitch and Grayer, 2008; Williams and
Grayer, 2004; Yoshida et al., 2009). It has been shown that anthocyanins
are potent antioxidants (Kahkonen and Heinonen, 2003; Kahkonen et
al., 2001) and have neuroprotective properties (Del Rio et al., 2010),
preventing neurotoxicity induced by reperfusion damagemodel of cere-
bral ischemia (Min et al., 2011; Shin et al., 2006), by deleterious effects
found in models of Parkinson's (Kim et al., 2010) and AD (Shih et al.,
2010). Altogether these evidences suggest that ﬂavonoid compounds
also have beneﬁcial effects on memory and cognition (Spencer, 2010).
In fact, it has been described that anthocyanins improve memory in
old rats in Morris water maze (Andres-Lacueva et al., 2005) and also
cognition in older humans (Krikorian et al., 2010).
In this context, we sought to investigate if anthocyanin treatment
prevented the scopolamine-induced memory deﬁcits and if the ecto-
nucleotidase enzymes as well as the ATP and adenosine levels are
involved.
Materials and methods
Chemicals
Nucleotides, Trizma Base, Percoll, and Coomassie Brilliant Blue G
were purchased from Sigma Chemical Co (St. Luis, MO, USA). Scopol-
amine HCI (SCO) was purchased from Sigma-Aldrich Chemie GmbH
(Schnelldorf, Germany), and anthocyanins were extracted and puriﬁed
from grape skin and gently donated by Christian Hansen A/S. All other
reagents used in the experiments were of analytical grade and of the
highest purity.
Animals
This study used three months old adult male Wistar rats (350–
400 g). They were kept in the Central Animal House of Federal Univer-
sity of Santa Maria in colony cages at an ambient temperature of 25±
2 °C and relative humidity of 45–55% with 12 h light/dark cycles. They
had free access to standard rodent pelleted diet and water ad libitum.
Experiments were conducted in accordance with the Institutional Ethi-
cal Committee of the Federal University of Santa Maria.
Exposure
Seven to ten animals per group were usually tested in the experi-
ments (Scheme 1). Rats were treated i.p. with Antho (200 mg kg−1
body weight) daily for 7 days (around 10 a.m.). The doses were cal-
culated as free base form. Scopolamine was dissolved in saline andScheme 1. Expoinjected i.p. at a dose of 1 mg kg−1, and administered 30 min after
the training in inhibitory avoidance apparatus in accordance with that
previously described (Ali and Arafa, 2011). The dose of anthocyanins
was chosen on the basis of previous studies indicating neuroprotection
(Manach et al., 2004; Saija et al., 1990; Varadinova et al., 2009). In addi-
tion, the daily intake of anthocyanins in the residents of the United
States is estimated to be about 200 mg or about 9-fold higher than
that of other dietary ﬂavonoids, and this also served as a basis for this
study (Manach et al., 2004; Wang and Stoner, 2008).
Behavioral procedure
Inhibitory avoidance task
In the ﬁnal day of treatment with anthocyanins (7th day), the an-
imals were subjected to training in a step-down inhibitory avoidance
apparatus in accordance with that previously described (Rubin et al.,
2000), and then the animals received SCO (i.p. 1 mg kg−1) 30 min
after training. Next, 24 h after the training the animals were sub-
jected to test in a step-down inhibitory avoidance task. Brieﬂy, the
rats were subjected to a single training session in a step-down inhib-
itory avoidance apparatus, which consisted of a 25×25×35-cm box
with a grid ﬂoor whose left portion was covered by a 7×25-cm plat-
form, 2.5 cm high. The rat was placed gently on the platform facing
the rear left corner, and when the rat stepped down with all four
paws on the grid, a 3-s 0.4-mA shock was applied to the grid. Reten-
tion test took place in the same apparatus 24 h later. Test step-down
latency was taken as a measure of retention, and a cut-off time of
300 s was established.
Open ﬁeld
Immediately after the inhibitory avoidance test session, the animals
were transferred to an open-ﬁeld measuring 56×40×30 cm, with the
ﬂoor divided into 12 squares measuring 12×12 cm each. The open
ﬁeld session lasted for 5 min and during this time, an observer, who
was not aware of the pharmacological treatments, recorded the number
of crossing responses and rearing responsesmanually. This testwas car-
ried out to identify motor disabilities, which might inﬂuence inhibitory
avoidance performance at testing.
Foot shock sensitivity test
Reactivity to shockwas evaluated in the same apparatus used for in-
hibitory avoidance, except that the platformwas removed andwas used
to determine the ﬂinch and jump thresholds in experimentally naïve
animals (Berlese et al., 2005; Rubin et al., 2000). The animals were
placed on the grid and allowed a 3 min habituation period before the
start of a series of shocks (1 s) delivered at 10 s intervals. Shock inten-
sities ranged from0.1 to 0.5 mA in 0.1 mA increments. The adjustments
in shock intensity were made in accordance with each animal's re-
sponse. The intensity was raised by one unit when no response oc-
curred and lowered by one unit when a response was made. A ﬂinchsure design.
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a jump response was deﬁned as withdrawal of three or four paws. Two
measurements of each threshold (ﬂinch, and jump)weremade, and the
mean of each score was calculated for each animal.
Brain tissue preparation
After behavioral tests, the animals were anesthetized under halo-
thane atmosphere before being killed by decapitation and brain
were removed and separated into cerebral cortex (CC) and hippocam-
pus (HC) and placed in a solution of Medium I (320 mM sucrose,
0.1 mM EDTA and 5 mM HEPES, pH 7.5) on ice (Gutierres et al.,
2012). The brain structures were gently homogenized in a glass potter
in Medium I. Protein was determined by the Coomassie Blue method
with that previously described (Bradford, 1976), using bovine serum
albumin as standard solution.
Synaptosome preparation
Synaptosomeswere isolated essentially as that previously described
(Nagy and Delgado-Escueta, 1984), using a discontinuous Percoll gradi-
ent. The CC and HC were gently homogenized in 10 volumes of an
ice-cold medium (medium I) containing 320 mM sucrose, 0.1 mM
EDTA and 5 mMHEPES, pH 7.5, in a motor driven Teﬂon-glass homog-
enizer and then centrifuged at 1000×g for 10 min. An aliquot of 0.5 ml
of the crude mitochondrial pellet was mixed with 4.0 ml of an 8.5%
Percoll solution and layered into an isoosmotic discontinuous Percoll/
sucrose gradient (10%/16%). The synaptosomes that banded at the 10/
16% Percoll interface were collected with a wide-tip disposable plastic
transfer pipette. The synaptosomal fraction was washed twice with an
isoosmotic solution consisting of 320 mM sucrose, 5.0 mM HEPES, pH
7.5, and 0.1 mMEDTA by centrifugation at 15,000 g to remove the con-
taminating Percoll. The pellet of the second centrifugation was
resuspended in an isoosmotic solution to a ﬁnal protein concentration
of 0.4–0.6 mg/ml. Synaptosomes were prepared fresh daily and
maintained at 0°–4° throughout the procedure and used for NTPDase
and 5′-nucleotidase assays.
Assay of lactate dehydrogenase
The integrity of the synaptosomes preparations was conﬁrmed by
determining the lactate dehydrogenase (LDH) activity which was
obtained after synaptosome lysis with 0.1% Triton X-100 and compar-
ing it with an intact preparation, using the Labtest kit (Labtest, Lagoa
Santa, MG, Brasil).
Assay of NTPDase and 5′-nucleotidase activities
The NTPDase enzymatic assay of the synaptosomes was carried out
in plates with a reaction medium containing 5 mM KCl, 1.5 mM CaCl2,
0.1 mM EDTA, 10 mM glucose, 225 mM sucrose and 45 mM Tris–HCl
buffer, pH 8.0, in a ﬁnal volume of 200 μl as described in a previous
work from our laboratory (Schetinger et al., 2000). The 5′-nucleotidase
activity was determined with that previously described (Heymann et
al., 1984) in a reaction medium containing 10 mM MgSO4 and
100 mMTris–HCl buffer, pH 7.5, in a ﬁnal volume of 200 μl. In synapto-
somes 20 μl of enzyme preparation (8–12 μg of protein) was added to
the reaction mixture and pre-incubated at 37 °C for 10 min. The reac-
tionwas initiated by the addition of ATP or ADP to obtain a ﬁnal concen-
tration of 1.0 mM and incubation proceeded for 20 min. For AMP
hydrolysis, the 5′-nucleotidase activity was carried out as previously
described and the ﬁnal concentration of the nucleotide AMP added
was 2 mM. The reactions were stopped by the addition of 200 μl of
10% trichloroacetic acid (TCA) to provide a ﬁnal concentration of 5%.
Subsequently, the tubes were chilled on ice for 10 min. Released inor-
ganic phosphate (Pi) was assayed using malachite green as thecolorimetric reagent and KH2PO4 as standard (Chan et al., 1986).
All samples were run in triplicate. Enzyme speciﬁc activities are
reported as nmol Pi released/min/mg of protein. Adenosine deaminase
activity was estimated spectrophotometrically by the method of Giusti
(1974), and the values were expressed as U/L of protein for ADA.
Analysis of purine levels in cerebral cortex and hippocampus by high
pressure liquid chromatography
Sample preparation
ATP and its breakdown products were extracted with that previous-
ly described (Ryder, 1985). Brieﬂy, different amounts of the CC or HC
were weighted and homogenized with 0.6 M perchloric acid at 0 °C
for 1 min with an Ultra-turrax homogenizer (model T 18, IKA® Works
Inc., Wilmington, Del., USA). The homogenate was centrifuged at
2000×g for 10 min, and the supernatant was immediately neutralized
to pH 6.5 to 6.8 with 1 M potassium hydroxide.
High performance liquid chromatography analysis
High performance liquid chromatography (HPLC) was performed
with a Shimadzu (Kyoto, Japan) equipment composed of a reciprocating
pumpmodel LC-20AT, a degassermodel DGU-20A5, a diode array detec-
tor (DAD) model SPD-M20A, auto-sampler (SIL-20A) and integrator
model CBM-20A, operated by the LC Solution 1.22 SP1 software. Separa-
tion was achievedwith a Phenomenex Synergi 4 μmFusion RP-80A col-
umn (150×4.60 mm, 4 μm) with precolumn, using 0.04 M potassium
dihydrogen orthophosphate (KH2PO4) and 0.06 M dipotassium hydro-
gen orthophosphate (K2HPO4) asmobile phase A and acetonitrile asmo-
bile phase B. A gradient elution was used according to the speciﬁcations
previously described (Scherer et al., 2005), at a ﬂow rate of 0.7 ml/min.
Mobile phases were ﬁltered through a 0.45 μm Millipore ﬁlter prior to
analysis, and all the reagents utilized were of HPLC grade. Purines in
the samples (ATP, ADP, AMP and adenosine) were identiﬁed by their re-
tention times andDAD spectrum (in the range 200–400 nm), and quan-
tiﬁed by comparison of the peak's area with standards. The results are
expressed by pmol of the different compounds per ml of sample.
Protein determination
Protein was measured by the Coomassie Blue method with that
previously described (Bradford, 1976), using bovine serum albumin
as standard.
Statistical analysis
Statistical analysis of latency test was carried by Scheirer–Ray–Hare
(extension of the Kruskal–Wallis test or two-way ANOVA). Foot shock
sensitivity test was analyzed by unpaired t test. Enzymatic activity, nu-
cleotide and nucleoside levels, crossing and rearing responses were an-
alyzed by one- or two-way ANOVA, followed by Tukey's multiple range
tests. Pb0.05 was considered to represent a signiﬁcant difference in all
experiments.
Results
Behavioral tests
Anthocyanins prevent the impairment of memory induced by scopolamine
Fig. 1 shows the effect of the treatment with anthocyanins (Antho)
and scopolamine-induced (SCO) memory deﬁcits, on step-down la-
tencies. Statistical analysis of testing (nonparametric two-way ANOVA)
showed a signiﬁcant scopolamine (1 mg kg−1) vs anthocyanins
(200 mg kg−1) or vehicle interaction (Control), revealing that treat-
ment with anthocyanins reverses the impairment of memory induced
by SCO [H=9.75; P 0.01]. Statistical analysis of training (one-way
ANOVA) showed no difference between groups [F(3,31)=0.77;
Fig. 1. Oral administration of anthocyanins (200 mg kg−1) once a day during 7 days
reverses the impairment of memory induced by scopolamine (1 mg kg−1) in adult
rats. Data are the median±interquartile range for 8–10 animals in each group.
*Pb0.05 compared with the other groups, #Pb0.05 compared with the scopolamine
(SCO) group by the Scheirer–Ray–Hare nonparametric multiple comparisons task.
1224 JM Gutierres et al. / Life Sciences 91 (2012) 1221–1228P 0.05]. Because motivational disparities in the training session may ac-
count for differences in inhibitory avoidance at testing, experiments
were performed to assess whether SCO or Antho affected shock thresh-
old, or locomotor ability of the animals. Statistical analysis of open-ﬁeld
data (one-way ANOVA) revealed that scopolamine did not alter the
number of crossing [F(3,31)=0.99; Pb0.05] or rearing [F(3,31)=
0.13; Pb0.05] responses in a subsequent open-ﬁeld test session,
suggesting that neither SCO nor Antho caused gross motor disabilities
at testing (Table 1). Moreover, SCO did not alter foot shock sensitivity,
as demonstrated by the similar ﬂinch [unpaired t test: F(3,31)=1.30;
P>0.05], jump [unpaired t test: F(3,31)=4.48; P>0.05] and vocaliza-
tion [unpaired t test: F(3,31)=1.11; P>0.05] thresholds exhibited by
the animals. These data suggest that neither treatment with Antho ad-
ministered before nor SCO administered after training of inhibitory
avoidance caused motor disabilities or altered foot shock sensitivity
(Table 1).Enzymatic activities
Anthocyanins prevent the increase in NTPDase activity induced by
scopolamine
Fig. 2 shows the effect of Antho and SCO on the activity of NTPDase
in the CC and HC of rats. SCO increased the NTPDase activity in the CC
(Fig. 2A) and HC (Fig. 2B) using ATP nucleotide as substrate. Antho
prevented the increase in NTPDase activity induced by SCO in the
CC [F(1,20)=7.371; P 0.05, Fig. 2A] and HC [F(1,20)=6.397; P 0.05,
Fig. 2B]. SCO also increased the NTPDase activity in HC using ADP nu-
cleotide as substrate and Antho prevents this effect [F(1,20)=6.397;
P 0.05, Fig. 2D]. No signiﬁcant differences in the activity of NTPDase in
the CC were observed in the groups [F(1,20)=0.002; P 0.05, Fig. 2C].Table 1
Effect of anthocyanins (200 mg kg−1) and scopolamine (1 mg kg−1) on the latency of train
immediately after the inhibitory avoidance testing session and on foot shock sensitivity (ﬂ
Group Training Crossing Rearing
Vehicle 7.50±1.99 21.75±3.13 16.00±2.28
Antho 8.37±1.79 17.25±2.19 13.63±2.09
SCO 5.30±1.59 22.10±2.57 18.00±2.96
SCO+Antho 8.22±1.35 23.89±3.01 20.22±2.36
Statistical analysis F(3,31)=0.77; P>0.05 F(3,31)=0.99; P>0.05 F(3,31)=1.30; P
Data are means±SEM for 6–10 animals in each group.Anthocyanins prevent the decrease in 5′-nucleotidase activity induced by
scopolamine
Fig. 3 shows the effect of Antho and SCO on the activity of
5′-nucleotidase in the CC (Fig. 3A) and HC (Fig. 3B) of rats. Scopol-
amine decreased the 5′-nucleotidase activity in the HC. Antho
prevented the decrease in 5′-nucleotidase activity induced by SCO
in the HC [F(1,20)=12.98; P 0.01, Fig. 3B]. No signiﬁcant differences
in the activity of 5′-Nucleotidase in the CC was observed [F(1,20)=
0.288; P 0.05, Fig. 3A].
Anthocyanins prevent the increase in adenosine deaminase activity
induced by scopolamine
Fig. 4 shows the effect of Antho and SCO on the activity of adenosine
deaminase in the CC (Fig. 4A) andHC (Fig. 4B) of rats. SCO increased the
adenosine deaminase activity in the HC. Antho prevented the increase
in adenosine deaminase activity induced by SCO in the HC [F(1,20)=
4.897, P 0.05, Fig. 4B]. No signiﬁcant differences in the activity of aden-
osine deaminase in the CC was observed [F(1,20)=0.071, P 0.05,
Fig. 4A].
Content of nucleotides and nucleosides of adenine
Anthocyanins can restore decrease in purine levels induced by scopolamine
Table 2 shows the effect of Antho and SCO on the nucleotide levels in
theCCof rats. SCOdecreased theATP levels CC in relation to the all groups.
However, when the animals received anthocyanins (SCO+Antho), the
levels of ATP were similar to those of the vehicle group [F(1,12)=
14.23; P 0.01]. No signiﬁcant differences in ADP [F(1,12)=0.036;
P 0.05], AMP [F(1,12)=3.002; P 0.05] and adenosine levels were ob-
served [F(1,12)=4.013; P 0.05].
Table 3 shows the effect of Antho and SCO on the nucleotides
levels in the HC of rats. SCO decreased the ATP levels in the HC in re-
lation to all the groups. However, when the animals received antho-
cyanins (SCO+Antho), the levels of ATP were similar to those of
the vehicle group [F(1,12)=5.648; P 0.05]. No signiﬁcant differences
in ADP [F(1,12)=3.593; P 0.05], AMP [F(1,12)=1.684; P 0.05] and
adenosine [F(1,12)=0.373; P 0.05] levels were observed.
Discussion
In the present study, we have evaluated the potential preventive
role of the anthocyanins (Antho) in the scopolamine-induced memo-
ry deﬁcits in rats. Our results have shown that scopolamine impaired
the memory consolidation in rats trained in the inhibitory avoidance
task. Interestingly, in this study we found that anthocyanins at a dose
of 200 mg kg−1 during 7 days did not improve the memory of rats in
the inhibitory avoidance task, but it prevented the memory deﬁcits
induced by scopolamine (SCO) (Scheme 1).
SCO is an alkaloid derived from Atropa belladonna (Zhang et al.,
2008) and acts as a competitive antagonist of the muscarinic acetyl-
choline receptor (mAChR) (Wang et al., 2003). For this reason, SCO
is used to compromise cholinergic neurotransmission and, in someing, and behavior of rats (number of crossing and rearing responses) in the open-ﬁeld
inch, jump and vocalization).
Flinch (mA) Jump (mA) Vocalization (mA)
0.36±0.01 0.45±0.02 0.35±0.05
0.41±0.03 0.36±0.02 0.41±0.03
0.34±0.01 0.43±0.02 0.44±0.02
0.37±0.03 0.33±0.02 0.41±0.03
>0.05 F(3,31)=1.30; P>0.05 F(3,31)=4.48; P>0.05 F(3,31)=1.11; P>0.05
Fig. 2. Effects of Antho and SCO on NTPDase activity in synaptosomes of the cerebral cortex and hippocampus using ATP (A and B) and ADP (C and D) respectively as substrates. Bars
represent the mean±SEM. *Represents a signiﬁcant difference in all groups, Pb0.05. (ANOVA two-way, Tukey test).
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impairment in cholinergic neurotransmission, such as AD (Christensen
et al., 1992; Kopelman and Corn, 1988; Wesnes et al., 1991).
It has been reported that dietary supplementation of antioxidant-
rich berries (e.g., blueberry, strawberry) can improve the learning and
memory in the aged animal (Williams and Grayer, 2004; Williams et
al., 2008). The daily intake of anthocyanin chosen for this study
(200 mg kg−1) is in agreementwith the consumption of that in the res-
idents of the United States population (Manach et al., 2004; Wang and
Stoner, 2008). Moreover, previous studies indicate that a daily intake
of 200 mg/kg of anthocyanins has protective effects in rats, mice and
humans (Bao et al., 2008a, 2008b; Choi et al., 2007; Heinonen, 2001)
and improve learning and memory in female rats ovariectomized
(Varadinova et al., 2009). Furthermore, there are few studies using
acute treatment with anthocyanins, because diverse number of ﬂavo-
noid compounds, including anthocyanins, seem to require a short-
term or long-term to accumulate and promote beneﬁcial effects in the
brain of rodents (Barros et al., 2006; Hassimotto and Lajolo, 2011; Ke
et al., 2011; Min et al., 2011; Yang et al., 2011). Acute doses of anthocy-
anins may result in immediate beneﬁcial changes on the peripheral ho-
meostasis and biochemical tissue parameters (Matsumoto et al., 2001;Fig. 3. Effects of Antho and SCO on 5′-nucleotidase activity in synaptosomes of the cerebral c
resents a signiﬁcant difference in all groups, Pb0.05. (ANOVA two-way, Tukey test).Rossi et al., 2003). However, no previous study of acute and subacute
doses of anthocyanins associated with learning and memory have
been observed at this point.
Additionally, studies have shown that Antho have the ability to im-
prove memory of old rats in Morris water maze (Andres-Lacueva et al.,
2005), and ofmice in the inhibitory avoidance task (Barros et al., 2006).
Interestingly, it was also shown to be a cognitive improvement in older
humans (Krikorian et al., 2010). In line with this view, studies with the
Cyanidin-3-O-glucopyranoside (Cy-3G), an isolated Antho and abun-
dant in colorful vegetables and fruits, has recently been identiﬁed as
potent neuroprotective phytochemical since this compound protects
against Aβ peptide-mediated cytotoxicity in SH-SY5Y neurocytes
(Tarozzi et al., 2008, 2007, 2010) and also can reduce cerebral ischemia
damage and age-related neuronal deﬁcits (Shin et al., 2006).
Despite SCO's classical use as an amnesic agent, there are a lot of dis-
crepancies in relation to SCO effects in locomotion. Some studies, in fact,
challenge the viability of SCO use as a cognitive impairer, questioning if
the alterations in behavior are related to peripheral locomotor effects,
instead of memory disruption (Klinkenberg and Blokland, 2010). As
shown in Table 1, there were no changes in none of the parameters
analyzed. We have also shown in a pilot test (data not shown) thatortex and hippocampus using AMP as substrate. Bars represent the mean±SEM. *Rep-
Fig. 4. Effects of Antho and SCO on adenosine deaminase activity in synaptosomes of
the cerebral cortex and hippocampus using adenosine as substrate. Bars represent
the mean±SEM. *Represents a signiﬁcant difference in all groups, Pb0.05. (ANOVA
two-way, Tukey test).
1226 JM Gutierres et al. / Life Sciences 91 (2012) 1221–1228exposure to SCO for 1 h immediately before inhibitory avoidance
training did not impact training performance, since control and
scopolamine-treated animals' training session latencies did not change.
In the brain, information storage is involved with an increase in efﬁ-
ciency of synaptic stimulatory pathways (Wieraszko, 1996; Wieraszko
and Ehrlich, 1994). Since the ﬁrst demonstration of ATP-dependent re-
lease of CNS stimulation (Holton, 1959), there is a growing interest in
the role of ATP and adenosine in synaptic transmission (Cunha and
Ribeiro, 2000). ATP and adenosine act as neurotransmitters modulating
purinergic and adenosinergic receptors, respectively (Zimmermann,
1996, 1999, 2006). It has been reported that ATP and adenosine modu-
late low term potentiation (LTP) and low term depression (LTD) in neu-
rons (de Mendonca et al., 2002; Fujii, 2004; Wieraszko and Ehrlich,
1994; Yamazaki et al., 2003) and also contribute to neuronal synaptic
plasticity (Costenla et al., 1999; de Mendonca and Ribeiro, 1997;
Wieraszko, 1996). These processes are related with learning and mem-
ory formation (Cooke and Bliss, 2006; Howland and Wang, 2008;
Lovinger, 2010; Malenka, 1994).
In CNS, the NTPDase is an important enzyme involved in the
purinergic neurotransmission. Our results show that an increase in theTable 2
Effect of anthocyanins (200 mg kg−1) and scopolamine (1 mg kg−1) on the nucleo-
tides levels (ATP, ADP, AMP and Adenosine) in the cerebral cortex of rats. The data
were analyzed by two-way ANOVA followed by Tukey's test and expressed in nmol of
nucleotide/mg of tissue. ⁎Represents a signiﬁcant difference in all groups, Pb0.05.
Groups ATP ADP AMP Adenosine
Vehicle 0.78±0.089 0.56±0.187 0.40±0.017 0.91±0.128
Antho 0.83±0.130 0.71±0.040 0.54±0.089 1.14±0.258
SCO 0.58±0.032⁎ 0.59±0.089 0.54±0.057 1.17±0.174
SCO+Antho 0.90±0.023 0.77±0.052 0.45±0.161 1.07±0.104
Statistical
analysis
F(1,12)=
14.23; Pb0.01
F(1,12)=
0.036; P>0.05
F(1,12)=
3.002; P>0.05
F(1,12)=
4.013; P>0.05
Data are means±SEM for 4 animals in each group (cerebral cortex).NTPDase activity in synaptosomes of the CC and HC in rats treated
with SCO leads to a reduction of extracellular ATP in the synaptic cleft,
whichmay impair the purinergic signaling since it reduces the availabil-
ity of extracellular ATP. In addition, these enzymes differ in their ratios
and preferably for the substrate hydrolysis. The NTPDase 1 hydrolyzes
ATP and ADP in the same way; also, NTPDases 2, 3 and 8 hydrolyze
ATP more than ADP, and NTPDase 4 preferentially hydrolyzes UDP
(Zimmermann, 2001). Based on these ﬁndings, we believe that the ef-
fects found in the hippocampus and cerebral cortex can be related to
the activity of different enzyme isoforms. Enzymatic hydrolysis of ATP
and ADP in the hippocampus suggests the involvement of NTPDase 1,
whereas in the cerebral cortex other isoforms with greater afﬁnity to
ATP can be involved (Fig. 2). Furthermore, the reduction on the ATP
levels can impair processes like the establishment of the neuronal LTP
(Fujii, 2004; Min et al., 2011; Wieraszko and Ehrlich, 1994; Yamazaki
et al., 2003) affecting memory formation (Cooke and Bliss, 2006;
Howland and Wang, 2008; Lovinger, 2010; Malenka, 1994). These re-
sults corroborate our ﬁndings when compared with thememory evalu-
ated in the inhibitory avoidance task, where the amnesic effect induced
by SCO was prevented by the treatment with Antho.
The next step was to assess the 5′-nucleotidase and adenosine de-
aminase activity. As it can be seen in Fig. 3, SCO decreased the activity
of 5′-nucleotidase in synaptosomes of the HC (Fig. 3B), and the treat-
ment with Antho was able to prevent this decrease. Furthermore, our
results showed that 5′-nucleotidase and ADA activities seem to be
more sensitive in the HC than CC, so we believe that ectonucleotidase
in the hippocampus is more affected by scopolamine (see Figs. 3 and
4). However, we can not exclude that speciﬁc regions of the cerebral
cortexwhich are known to participate inmemory formation, as the pos-
terior cingulate and entorhinal cortex (Lima et al., 2009; Pereira et al.,
2005, 2001; Souza et al., 2002), are also affected by SCO administration,
so ectonucleotidase activities weremeasured in thewhole cerebral cor-
tex and not in speciﬁc regions, might have been the reason that no sig-
niﬁcant differenceswere observed in this brain structure. The activity of
this enzyme is very important because this leads to production of extra-
cellular adenosine (Burnstock, 2006a, b; Robson et al., 2006; Schetinger
et al., 2001). It was also observed that SCO increased the activity of
adenosine deaminase, and this effect was prevented by the treatment
with Antho. The 5′-nuleotidase and adenosine deaminase are key-
enzymes in the regulation of extracellular levels of adenosine in the
synaptic cleft. A decrease of 5′-nucleotidase activity reduces the adeno-
sine formation and the increase of adenosine deaminase activity in-
creases the hydrolysis of adenosine to inosine. Thus, the effect of SCO
on these enzymes leads to an increased removal of extracellular adeno-
sine decreasing its levels, which may lead to impairment of the ade-
nosinergic neurotransmission.
The depletion of extracellular adenosine can disrupt memory forma-
tion since adenosinehas been reported as an important neuromodulator
in the establishment of LTP and LTD, as well as in synaptic plasticity (de
Mendonca et al., 2002), (Costenla et al., 1999; deMendonca and Ribeiro,
1997; Wieraszko, 1996). Based on the activity of the ectonucleotidases,
it can be seen that the treatment with SCO increased the hydrolysis ofTable 3
Effect of anthocyanins (200 mg kg−1) and scopolamine (1 mg kg−1) on the nucleo-
tides levels (ATP, ADP, AMP and Adenosine) in the hippocampus of rats. The data
were analyzed by two-way ANOVA followed by Tukey's test and expressed in nmol of
nucleotide/mg of tissue. ⁎Represents a signiﬁcant difference in all groups, Pb0.05.
Groups ATP ADP AMP Adenosine
Vehicle 1.0±0.044 0.39±0.089 0.22±0.090 0.46±0.087
Antho 0.93±0.030 0.45±0.064 0.28±0.080 0.54±0.110
SCO 0.44±0.023⁎ 0.46±0.059 0.30±0.100 0.59±0.094
SCO+Antho 0.89±0.043 0.41±0.056 0.26±0.089 0.51±0.098
Statistical
analysis
F(1,12)=
5.648; Pb0.05
F(1,12)=
3.593; P>0.05
F(1,12)=1.
648; P>0.05
F(1,12)=
0.375; P>0.05
Data are means±SEM for 4 animals in each group (hippocampus).
1227JM Gutierres et al. / Life Sciences 91 (2012) 1221–1228extracellular ATP and adenosine. The reduction of these neurotransmit-
ters can reduce the signaling of adenosinergic and purinergic neuro-
transmission, respectively, and compromise the acquisition of memory
formation. However, studies showing the effect of SCO and Antho on
the activity of ectonucleotidases are limited. The possible mechanism
by which SCO and Antho act on these enzymes needs to be further
investigated.
Studies have shown that SCO impairs energy metabolism and
reduces the ATP levels in the CC of rats (Blin et al., 1994; Ray et al.,
1992). It is known that worsening of mitochondrial function and reduc-
tion of ATP levels are pathological conditions found in neurodegenera-
tive diseases such as AD, which is closely linked to the decline of
cognitive processes (Ferrer, 2009;Hauptmann et al., 2009). Other studies
also show that SCO reduces the frontal cortex perfusion in young
humans (Honer et al., 1988). In addition, it was also observed that intra-
muscular SCO administration impairs the oxygen consumption and the
tissue metabolism of the cardiovascular system and CNS of humans
(Kirvela et al., 1994). The glucose treatment was able to prevent deﬁcits
on thememory induced by SCO (Stone et al., 1991). Based on these ﬁnd-
ings, the deleterious effects of SCO could be related to energy depletion in
neurons. Thus, the second set of experiments investigated the levels of
nucleotides ATP, ADP and AMP and the nucleoside adenosine in the CC
and HC in the animals studied.
As it can be seen, SCO reduced the levels of ATP in the CC (Table 2)
and HC (Table 3) of rats. The treatment with Antho prevented the de-
pletion of ATP tissue in both structures. To explain this effect, the pos-
sible mechanism could be related to the vasodilatory capacity of
anthocyanins (Mudnic et al., 2011). It has been shown that anthocy-
anins effectively enhanced neuronal function (Vafeiadou et al.,
2007; Ward et al., 2002), stimulating neuronal regeneration and re-
vascularization (Havsteen, 2002; Singh et al., 2008). In addition,
more studies also report that anthocyanins may actually cross the
blood brain barrier (Youdim et al., 2003). Anthocyanins induced vaso-
dilatation through its property to activate endothelial nitric oxide
synthase and increase nitric oxide production (Bell and Gochenaur,
2006; Edirisinghe et al., 2011; Wallerath et al., 2005). As it can be
seen, anthocyanin itself has no effect in the nucleotide and nucleoside
levels, but prevents the ATP depletion induced by SCO. Possible
mechanisms by which anthocyanins can re-establishment ATP levels
can occur through its vasodilatory properties.
Conclusion
In conclusion, we have shown that anthocyanins antagonized
scopolamine-induced performance deﬁcits in rats in the inhibitory
avoidance task. Thus, we suggest that in addition to the cholinergic
pathway classically affected by scopolamine, it is possible that pu-
rinergic system may be involved through unknown mechanisms, be-
cause we found a marked reduction in ATP levels and changes in
ectonucleotidase activities. However, the treatment with anthocya-
nins reestablished ATP levels in the brain, suggesting that this com-
pound is involved in the extracellular catabolism of nucleotides.
More experiments are already being conducted to investigate possi-
ble biochemical targets of polyphenols in the scopolamine-induced
memory deﬁcits.
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